PubRank

G Venkataraman

Author PubWeight™ 24.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Heparin and heparan sulfate: biosynthesis, structure and function. Curr Opin Chem Biol 2000 1.75
2 Cell surface glypicans are low-affinity endostatin receptors. Mol Cell 2001 1.51
3 Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin. Proc Natl Acad Sci U S A 2000 1.27
4 Heparin-induced self-association of fibroblast growth factor-2. Evidence for two oligomerization processes. J Biol Chem 1997 1.19
5 Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. J Clin Endocrinol Metab 1997 1.16
6 On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans. Angiogenesis 1997 1.12
7 Heparinase III from Flavobacterium heparinum: cloning and recombinant expression in Escherichia coli. Biochem Biophys Res Commun 1996 1.08
8 Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site. Proc Natl Acad Sci U S A 2000 1.07
9 Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma. Leuk Lymphoma 2006 1.03
10 Direct isolation and sequencing of specific protein-binding glycosaminoglycans. Nat Med 2001 0.98
11 Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum. Biochem J 1996 0.94
12 Recombinant expression, purification, and kinetic characterization of chondroitinase AC and chondroitinase B from Flavobacterium heparinum. Biochem Biophys Res Commun 2001 0.91
13 Probing fibroblast growth factor dimerization and role of heparin-like glycosaminoglycans in modulating dimerization and signaling. J Biol Chem 2001 0.89
14 Heparinase I from Flavobacterium heparinum. Mapping and characterization of the heparin binding domain. J Biol Chem 1996 0.88
15 FGF-2/fibroblast growth factor receptor/heparin-like glycosaminoglycan interactions: a compensation model for FGF-2 signaling. FASEB J 1999 0.86
16 Heparinase I from Flavobacterium heparinum: the role of the cysteine residue in catalysis as probed by chemical modification and site-directed mutagenesis. Biochemistry 1995 0.84
17 Oligomeric self-association of basic fibroblast growth factor in the absence of heparin-like glycosaminoglycans. Biochem J 1999 0.84
18 Process simulation for recombinant protein production: cost estimation and sensitivity analysis for heparinase I expressed in Escherichia coli. Biotechnol Bioeng 1997 0.84
19 Demystifying "exact" logistic regression for pathologists. J Clin Pathol 2008 0.82
20 The calcium-binding sites of heparinase I from Flavobacterium heparinum are essential for enzymatic activity. J Biol Chem 1999 0.82
21 Distinct heparan sulfate glycosaminoglycans are responsible for mediating fibroblast growth factor-2 biological activity through different fibroblast growth factor receptors. FASEB J 2001 0.79
22 Heparinase treatment of bovine smooth muscle cells inhibits fibroblast growth factor-2 binding to fibroblast growth factor receptor but not FGF-2 mediated cellular proliferation. Angiogenesis 1999 0.79
23 Single-stranded DNA and RNA targeted triplex-formation: UV, CD and molecular modeling studies of foldback triplexes containing different RNA, 2'-OMe-RNA and DNA strand combinations. J Biomol Struct Dyn 1997 0.79
24 Single strand targeted triplex formation: targeting purine-pyrimidine mixed sequences using abasic linkers. Nucleic Acids Res 1995 0.79
25 Development of risk assessment tool for foundry workers. Work 2008 0.77
26 Renal FNA-based typing of renal masses remains a useful adjunctive modality: evaluation of 31 renal masses with correlative histology. Cytopathology 2008 0.76
27 Renal damage and glue sniffing. Br Med J (Clin Res Ed) 1981 0.75
28 Stopping powers of some low atomic number materials for alpha particles of energies up to MeV. Health Phys 1975 0.75
29 Experience in fast neutron personnel monitoring in India. Health Phys 1981 0.75
30 Auer rods in hand mirror cells in a case of acute myeloid leukemia. Acta Haematol 2000 0.75
31 Revised parameters for use in Loevinger's beta point-source dose-distribution function. J Nucl Med 1973 0.75
32 A stationary neutron monitor for criticality accidents. Health Phys 1975 0.75
33 Shielding calculations below 100 kVp. Health Phys 1982 0.75
34 Endocrine glands in anencephaly. Indian J Pediatr 1973 0.75
35 Use of NTA films as neutron monitors in criticality accidents. Health Phys 1975 0.75
36 A beta blocker-thiazide combination in the treatment of hypertension in diabetics. Br J Clin Pract 1982 0.75
37 Radiation hazards from 241Am sources used in thyroid studies. J Nucl Med 1976 0.75
38 Clinical quiz. Hepatitis A. J Pediatr Gastroenterol Nutr 2000 0.75
39 Neutron dose distributions for californium-252 sources. Int J Appl Radiat Isot 1971 0.75
40 The recoil proton dose across a bone-tissue interface due to fast neutrons. Phys Med Biol 1971 0.75
41 Californium-252 line sources: experimental verification of depth dose data using NTA films and dosage tables based on Paterson and Parker rules. Phys Med Biol 1976 0.75